UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

Journal of Neural Transmission, 2021-03, Vol.128 (3), p.321-335

2021

Volltextzugriff (PDF)

Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement

Journal of Neurology, 2015-10, Vol.262 (10), p.2201-2213

2015

Volltextzugriff (PDF)

Improvement of Dystonia Management by Specific Training of General Neurologist and Family Doctors (P3.018)

Neurology, 2017-04, Vol.88 (16_supplement)

Relja, Maja

2017

Volltextzugriff (PDF)

De-novo Amantadine Treatment Delays Onset of Dyskinesias in Patients with Parkinson Disease (I3-5A)

Neurology, 2015-04, Vol.84 (14_supplement)

Relja, Maja

2015

Volltextzugriff (PDF)

De-novo Amantadine Treatment Delays Onset of Dyskinesias in Patients with Parkinson Disease (P1.188)

Neurology, 2015-04, Vol.84 (14_supplement)

Relja, Maja

2015

Volltextzugriff (PDF)

Assessment of non-motor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia previously not treated with botulinum toxin: a single-centre case-controled study (P5.043)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

When movement disorders hurt: Addressing pain in hyperkinetic disorders

Parkinsonism & related disorders, 2017-11, Vol.44, p.110-113

2017

Volltextzugriff (PDF)

Clinical rating scales

Parkinsonism & related disorders, 2012, Vol.18, p.S229-S232

Relja, Maja

2012

Volltextzugriff (PDF)

Effect of botulinum toxin type A treatment on nonmotor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia

Toxicon (Oxford), 2018, Vol.156, p.S97

2018

Volltextzugriff (PDF)

Centrally transported botulinum toxin type A relieves local spastic paralysis

Toxicon (Oxford), 2018-12, Vol.156, p.S78-S78

2018

Volltextzugriff (PDF)

Management and Quality of Life of Dystonia Patients in Europe: A Survey Towards Care from a Patients’ Experience (826)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Cephalalgia, 2010-07, Vol.30 (7), p.804-814

2010

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Cephalalgia, 2010-07, Vol.30 (7), p.793-803

2010

Volltextzugriff (PDF)

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : A cross-sectional study

Journal of neurology, 2007-12, Vol.254 (12), p.1676-1683

2007

Volltextzugriff (PDF)

Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy

Journal of neurology, 2018-04, Vol.265 (4), p.856-862

2018

Volltextzugriff (PDF)

Effect of botulinum toxin type-A treatment on non-motor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia

Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2018, Vol.WCP2018, p.PO4-1-61

2018

Volltextzugriff (PDF)

Brainstem nuclei changes in migraine detected by transcranial sonography

Neurological sciences, 2017-08, Vol.38 (8), p.1509-1512

2017

Volltextzugriff (PDF)

Citalopram-induced parkinsonian syndrome: case report

Clinical neuropharmacology, 2011-03, Vol.34 (2), p.92-93

2011

Volltextzugriff (PDF)

Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration

Metabolic brain disease, 2014-03, Vol.29 (1), p.207-209

2014

Volltextzugriff (PDF)

Optimising effects of botulinum toxin by post-injection activity

Toxicon (Oxford), 2008-06, Vol.51, p.18-19

Maja, Relja

2008

Volltextzugriff (PDF)

Strategies for treatment of dystonia

Journal of Neural Transmission, 2016-03, Vol.123 (3), p.251-258

2016

Volltextzugriff (PDF)

A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease

Journal of the neurological sciences, 2006-10, Vol.248 (1), p.251-254

2006

Volltextzugriff (PDF)

Cerebral sinuvenous thrombosis: a rare complication of Lyme neuroborreliosis

Wiener Klinische Wochenschrift, 2015-01, Vol.127 (1-2), p.65-67

2015

Volltextzugriff (PDF)

Collet-Sicard syndrome as a complication of chronic middle ear infection

Clinical case reports and reviews, 2016, Vol.2 (8)

2016

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement

Improvement of Dystonia Management by Specific Training of General Neurologist and Family Doctors (P3.018)

De-novo Amantadine Treatment Delays Onset of Dyskinesias in Patients with Parkinson Disease (I3-5A)

De-novo Amantadine Treatment Delays Onset of Dyskinesias in Patients with Parkinson Disease (P1.188)

Assessment of non-motor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia previously not treated with botulinum toxin: a single-centre case-controled study (P5.043)

When movement disorders hurt: Addressing pain in hyperkinetic disorders

Clinical rating scales

Effect of botulinum toxin type A treatment on nonmotor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia

Centrally transported botulinum toxin type A relieves local spastic paralysis

Management and Quality of Life of Dystonia Patients in Europe: A Survey Towards Care from a Patients’ Experience (826)

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : A cross-sectional study

Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy

Effect of botulinum toxin type-A treatment on non-motor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia

Brainstem nuclei changes in migraine detected by transcranial sonography

Citalopram-induced parkinsonian syndrome: case report

Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration

Optimising effects of botulinum toxin by post-injection activity

Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force

Strategies for treatment of dystonia

A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease

Cerebral sinuvenous thrombosis: a rare complication of Lyme neuroborreliosis

Collet-Sicard syndrome as a complication of chronic middle ear infection

Aktive Filter

Suchergebnisse filtern